These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35557495)

  • 1. Prescription Patterns of Oral Corticosteroids for Asthma Treatment and Related Asthma Phenotypes in University Hospitals in Korea.
    Kwon JW; Kim MA; Sim DW; Lee HY; Rhee CK; Yang MS; Shim JS; Kim MH; Kim SR; Park CS; Kim BK; Kang SY; Choi GS; Lee H; Jang AS; Kim SH;
    Allergy Asthma Immunol Res; 2022 May; 14(3):300-313. PubMed ID: 35557495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overuse of Oral Corticosteroids in Asthma Is Often Underdiagnosed and Inadequately Addressed.
    van der Meer AN; de Jong K; Ferns M; Widrich C; Ten Brinke A
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2093-2098. PubMed ID: 35405380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world impact of mepolizumab in patients with life-threatening asthma: US insurance claims database analysis.
    Silver J; Molfino N; Bogart M; Packnett ER; McMorrow D; Wu J; Hahn B
    Clin Ther; 2021 Dec; 43(12):2064-2073. PubMed ID: 34893348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma.
    Makhinova T; Barner JC; Richards KM; Rascati KL
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK.
    Tran TN; King E; Sarkar R; Nan C; Rubino A; O'Leary C; Muzwidzwa R; Belton L; Quint JK
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32165402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
    Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C
    Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
    Menzella F; Bargagli E; Aliani M; Bracciale P; Brussino L; Caiaffa MF; Caruso C; Centanni S; D'Amato M; Del Giacco S; De Michele F; Di Marco F; Pastorello EA; Pelaia G; Rogliani P; Romagnoli M; Schino P; Senna G; Vultaggio A; Simoni L; Ori A; Boarino S; Vitiello G; Altieri E; Canonica GW
    Respir Res; 2022 Feb; 23(1):36. PubMed ID: 35183167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence.
    Calzetta L; Aiello M; Frizzelli A; Bertorelli G; Rogliani P; Chetta A
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of oral corticosteroids prescriptions in children with asthma in early childhood.
    Arabkhazaeli A; Vijverberg SJ; van der Ent CK; Raaijmakers JA; Maitland-van der Zee AH
    J Asthma; 2016 Dec; 53(10):1012-7. PubMed ID: 27187595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis.
    Sá-Sousa A; Almeida R; Vicente R; Nascimento N; Martins H; Freitas A; Fonseca JA
    Clin Transl Allergy; 2019; 9():47. PubMed ID: 31559008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma.
    Tran TN; MacLachlan S; Hicks W; Liu J; Chung Y; Zangrilli J; Rubino A; Ganz ML
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):338-346.e3. PubMed ID: 32569754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral corticosteroid exposure and adverse effects in asthmatic patients.
    Sullivan PW; Ghushchyan VH; Globe G; Schatz M
    J Allergy Clin Immunol; 2018 Jan; 141(1):110-116.e7. PubMed ID: 28456623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma.
    Wechsler ME; Colice G; Griffiths JM; Almqvist G; Skärby T; Piechowiak T; Kaur P; Bowen K; Hellqvist Å; Mo M; Garcia Gil E
    Respir Res; 2020 Oct; 21(1):264. PubMed ID: 33050928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Oral Corticosteroid Users Among Persons with Asthma on GINA Step 3 Therapy and Above: A Cross-Sectional Study in Portuguese Community Pharmacies.
    Romão M; Bulhosa C; Mendes Z; Sousa C; Silva G; Pereira M; Bernardo F; Teixeira Rodrigues A; Fonseca JA; Correia de Sousa J
    J Asthma Allergy; 2022; 15():1579-1592. PubMed ID: 36387837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.
    Lommatzsch M; Sauerbeck IS; Wilmer C; Taube C
    Respir Med; 2021 Jan; 176():106242. PubMed ID: 33253969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study.
    Papaioannou AI; Mplizou M; Porpodis K; Fouka E; Zervas E; Samitas K; Markatos M; Bakakos P; Papiris S; Gaga M; Papakosta D; Loukides S
    Allergy Asthma Proc; 2021 May; 42(3):235-242. PubMed ID: 33980337
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use.
    Zazzali JL; Broder MS; Omachi TA; Chang E; Sun GH; Raimundo K
    Allergy Asthma Proc; 2015; 36(4):268-74. PubMed ID: 26108084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study.
    Khurana S; Brusselle GG; Bel EH; FitzGerald JM; Masoli M; Korn S; Kato M; Albers FC; Bradford ES; Gilson MJ; Price RG; Humbert M
    Clin Ther; 2019 Oct; 41(10):2041-2056.e5. PubMed ID: 31447130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma.
    Silver J; Bogart M; Packnett E; Wu J; McMorrow D; Hahn B
    J Asthma Allergy; 2020; 13():689-699. PubMed ID: 33364788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study.
    Fukunaga K; Tagaya E; Ishida M; Sunaga Y; Koshiba R; Yokoyama A
    Allergol Int; 2023 Oct; 72(4):537-544. PubMed ID: 37117134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.